Catalys Pacific

Catalys Pacific is a biotech investment and company-building firm that creates and develops new biotech companies by leveraging partnerships and networks across Japan and the United States. The firm focuses on early-stage opportunities in areas such as hypertension, renal disease, and chronic kidney disease to develop therapeutics for patients globally.